KindlyMD (NASDAQ:NAKA) Shares Down 7.2% - What's Next?

Key Points

• KindlyMD's shares fell 7.2% on Tuesday, trading as low as $4.96 before recovering slightly to $5.05.
• The company's recent earnings report revealed a loss of ($0.34) earnings per share and a revenue of only $0.41 million.
• With a market capitalization of $1.81 billion, KindlyMD is facing significant challenges, reflected by a negative return on equity of 131.09%.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) shares fell 7.2% during mid-day trading on Tuesday . The stock traded as low as $4.96 and last traded at $5.05. 170,075 shares were traded during trading, a decline of 94% from the average session volume of 2,962,074 shares. The stock had previously closed at $5.44.

Wall Street Analysts Forecast Growth

Separately, Maxim Group assumed coverage on shares of KindlyMD in a report on Wednesday. They set a "buy" rating and a $8.00 price objective on the stock. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $8.00.

KindlyMD Trading Up 24.4%

The company has a market cap of $1.53 billion, a price-to-earnings ratio of -4.74 and a beta of 33.96. The stock's 50 day moving average is $9.99.

KindlyMD (NASDAQ:NAKA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share (EPS) for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The company had revenue of $0.41 million for the quarter.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.